Trials that use: Fisher exact test
New to this method? Read the tutorial →
4,441 results
- A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.: Complete Statistical AnalysisIndependent statistical analysis of A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.: Complete Statistical AnalysisIndependent statistical analysis of A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.: Complete Statistical AnalysisIndependent statistical analysis of A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Cephalexin Suspension in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Cephalexin Suspension in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02123459).
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B: primary endpoint results, effect estimate with confidence…
- A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2): Complete Statistical AnalysisIndependent statistical analysis of A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2): primary…
- A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia: Complete Statistical AnalysisIndependent statistical analysis of A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis: primary endpoint results, effect estimate with confidence…
- A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): Complete Statistical AnalysisIndependent statistical analysis of A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn: Complete Statistical AnalysisIndependent statistical analysis of A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Different Particle Sizes of Evacetrapib in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Different Particle Sizes of Evacetrapib in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Donanemab (LY3002813) in Healthy Chinese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Donanemab (LY3002813) in Healthy Chinese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05533411).
- A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum: Complete Statistical AnalysisIndependent statistical analysis of A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05569252).
- A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: Complete Statistical AnalysisIndependent statistical analysis of A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638802).
- A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: Complete Statistical AnalysisIndependent statistical analysis of A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy: primary endpoint results, effect estimate with confidence interval,…
- A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: Complete Statistical AnalysisIndependent statistical analysis of A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of E7080 in Subjects With Advanced Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of E7080 in Subjects With Advanced Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01728623).
- A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: primary…
- A Study of EMD525797 in Solid Tumor Patients in Japan: Complete Statistical AnalysisIndependent statistical analysis of A Study of EMD525797 in Solid Tumor Patients in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01327313).
- A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): Complete Statistical AnalysisIndependent statistical analysis of A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01825876).
- A Study of Evacetrapib in Healthy Female Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Evacetrapib in Healthy Female Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01746732).
- A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis: primary endpoint results, effect estimate with confidence interval,…
- A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158): Complete Statistical AnalysisIndependent statistical analysis of A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of FMT in Patients With AML Allo HSCT in Recipients: Complete Statistical AnalysisIndependent statistical analysis of A Study of FMT in Patients With AML Allo HSCT in Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04085289).
- A Study of Galcanezumab in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galcanezumab in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02576951).
- A Study of Galunisertib in Participants With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galunisertib in Participants With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02008318).
- A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive…
- A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: primary endpoint results, effect…
- A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.: primary endpoint results, effect…
- A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH: Complete Statistical AnalysisIndependent statistical analysis of A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764474).
- A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Immunogenicity and Safety of GSK Biologicals’ Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202): Complete Statistical AnalysisIndependent statistical analysis of A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations: primary endpoint…
- A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion: Complete Statistical AnalysisIndependent statistical analysis of A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…